ImClone Investigational Site

Stony Brook, New York 11794

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Colorectal Cancer

Studies at this site

• Study of Icrucumab (IMC-18F1) or Ramucirumab Drug Product (DP) in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer Patients — Completed
• Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer — Completed